US Patent 7777077 Dual-acting antihypertensive agents
Patent 7777077 was granted and assigned to Theravance on August, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+67 characters)
Article
Patent abstract
The invention is directed to compounds of formula I:
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Keith Jendza0
Paul R. Fatheree0
Robert M. McKinnell0
Ryan Hudson0
Seok-Ki Choi0
Vivek Sasikumar0
Edits on 26 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07777077 Dual-acting antihypertensive agents US Patent 7777077 Dual-acting antihypertensive agents
Infobox
Patent Number
077770770
Patent Number
77770770
Edits on 1 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
077770770
Date of Patent
August 17, 2010
0Patent Application Number
120121610
Date Filed
January 31, 2008
0Official Website
Patent Primary Examiner
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 5 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07777077 Dual-acting antihypertensive agents
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07777077
Date of patent
August 17, 2010
Patent application number
12012161
Date Filed
January 31, 2008
Patent primary examiner
Find more entities like US Patent 7777077 Dual-acting antihypertensive agents
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
